Derma Sciences Company Profile (NASDAQ:DSCI)

About Derma Sciences (NASDAQ:DSCI)

Derma Sciences logoDerma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company's advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products principally consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners and skin care products. The Company's traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Symbol: NASDAQ:DSCI
  • CUSIP: 24982750
  • Web: www.dermasciences.com
Average Prices:
  • 50 Day Moving Avg: $6.82
  • 200 Day Moving Avg: $5.28
  • 52 Week Range: $2.92 - $7.05
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -63.64
  • P/E Growth: 0.00
Profitability:
  • Net Margins: -12.32%
  • Return on Equity: -4.09%
  • Return on Assets: -3.22%
Debt:
  • Current Ratio: 1.29%
  • Quick Ratio: 1.02%
Misc:
  • Average Volume: 435,924 shs.
  • Beta: 1.03
 

Frequently Asked Questions for Derma Sciences (NASDAQ:DSCI)

What is Derma Sciences' stock symbol?

Derma Sciences trades on the NASDAQ under the ticker symbol "DSCI."

How were Derma Sciences' earnings last quarter?

Derma Sciences Inc (NASDAQ:DSCI) announced its quarterly earnings results on Tuesday, August, 9th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.08) by $0.16. The business earned $22.20 million during the quarter, compared to the consensus estimate of $22.40 million. Derma Sciences had a negative return on equity of 4.09% and a negative net margin of 12.32%. View Derma Sciences' Earnings History.

Who are some of Derma Sciences' key competitors?

Who owns Derma Sciences stock?

Derma Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional investors include FNY Partners Fund LP (0.00%). Company insiders that own Derma Sciences stock include Brett Hewlett, Bruce F Wesson, Edward J Quilty, Robert C Cole, Samuel E Navarro and Srini Conjeevaram. View Institutional Ownership Trends for Derma Sciences.

Who bought Derma Sciences stock? Who is buying Derma Sciences stock?

Derma Sciences' stock was bought by a variety of institutional investors in the last quarter, including FNY Partners Fund LP. Company insiders that have bought Derma Sciences stock in the last two years include Bruce F Wesson, Edward J Quilty, Robert C Cole, Samuel E Navarro and Srini Conjeevaram. View Insider Buying and Selling for Derma Sciences.

How do I buy Derma Sciences stock?

Shares of Derma Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Derma Sciences stock cost?

One share of Derma Sciences stock can currently be purchased for approximately $7.00.

Analyst Ratings

Consensus Ratings for Derma Sciences (NASDAQ:DSCI) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Derma Sciences (NASDAQ:DSCI)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
1/18/2017Roth CapitalDowngradeBuy -> NeutralN/AView Rating Details
1/9/2016Oppenheimer Holdings Inc.Reiterated RatingBuyN/AView Rating Details
1/7/2016Canaccord GenuityDowngradeBuy -> Hold$4.00N/AView Rating Details
11/16/2015Piper Jaffray CompaniesLower Price TargetNeutral$6.00 -> $4.00N/AView Rating Details
(Data available from 5/27/2015 forward)

Earnings

Earnings History for Derma Sciences (NASDAQ:DSCI)
Earnings by Quarter for Derma Sciences (NASDAQ:DSCI)
Earnings History by Quarter for Derma Sciences (NASDAQ:DSCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016Q316($0.04)($0.05)$23.90 million$21.80 millionViewListenView Earnings Details
8/9/2016Q216($0.08)$0.08$22.40 million$22.20 millionViewListenView Earnings Details
5/11/2016Q116($0.13)($0.07)$20.60 million$20.20 millionViewListenView Earnings Details
11/9/2015Q315($0.43)($0.35)$22.31 million$22.20 millionViewListenView Earnings Details
8/10/2015Q215($0.43)($0.36)$21.66 million$22.60 millionViewListenView Earnings Details
5/11/2015Q115($0.46)($0.42)$19.89 million$19.50 millionViewListenView Earnings Details
3/12/2015Q414($0.46)($0.37)$22.90 million$22.90 millionViewListenView Earnings Details
11/10/2014Q314($0.43)($0.45)$21.90 million$20.20 millionViewN/AView Earnings Details
8/7/2014Q2($0.46)($0.34)$21.31 million$20.92 millionViewListenView Earnings Details
5/8/2014Q1($0.28)($0.46)$19.79 million$19.80 millionViewListenView Earnings Details
3/14/2014Q4($0.36)($0.31)$21.26 million$20.70 millionViewListenView Earnings Details
11/13/2013Q3($0.44)($0.29)$21.96 million$22.10 millionViewListenView Earnings Details
8/12/2013Q2 2013($0.45)($0.43)$19.95 million$18.10 millionViewListenView Earnings Details
5/16/2013Q1 2013($0.37)($0.38)$19.00 million$18.80 millionViewListenView Earnings Details
11/12/2012Q312($0.37)($0.24)$19.00 million$19.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Derma Sciences (NASDAQ:DSCI)
Current Year EPS Consensus Estimate: $-0.10 EPS
Next Year EPS Consensus Estimate: $-0.11 EPS

Dividends

Dividend History for Derma Sciences (NASDAQ:DSCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Derma Sciences (NASDAQ:DSCI)
Insider Ownership Percentage: 9.94%
Institutional Ownership Percentage: 58.89%
Insider Trades by Quarter for Derma Sciences (NASDAQ:DSCI)
Institutional Ownership by Quarter for Derma Sciences (NASDAQ:DSCI)
Insider Trades by Quarter for Derma Sciences (NASDAQ:DSCI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/18/2015Srini ConjeevaramDirectorBuy1,100$6.50$7,150.00View SEC Filing  
8/14/2015Samuel E NavarroDirectorBuy10,000$6.51$65,100.00View SEC Filing  
8/13/2015Bruce F WessonDirectorBuy10,000$6.58$65,800.00View SEC Filing  
8/13/2015Edward J QuiltyCEOBuy15,000$6.65$99,750.00View SEC Filing  
8/13/2015Robert C ColeInsiderBuy5,000$6.73$33,650.00View SEC Filing  
6/12/2015Brett HewlettDirectorSell12,000$7.17$86,040.00View SEC Filing  
12/15/2014Srini ConjeevaramDirectorSell12,500$8.49$106,125.00View SEC Filing  
12/4/2014C Richard StaffordDirectorSell6,075$8.59$52,184.25View SEC Filing  
11/25/2014C Richard StaffordDirectorSell1,775$8.26$14,661.50View SEC Filing  
11/18/2014C Richard StaffordDirectorSell3,250$8.59$27,917.50View SEC Filing  
11/17/2014C Richard StaffordDirectorSell1,800$8.50$15,300.00View SEC Filing  
11/14/2014C Richard StaffordDirectorSell5,073$8.48$43,019.04View SEC Filing  
9/16/2014Barry WolfensonInsiderBuy3,750$7.99$29,962.50View SEC Filing  
5/19/2014Barry WolfensonInsiderBuy11,250$8.79$98,887.50View SEC Filing  
5/16/2014Edward QuiltyCEOBuy10,000$8.70$87,000.00View SEC Filing  
1/10/2014Ra Capital Management, LlcInsiderSell300,000$11.83$3,549,000.00View SEC Filing  
9/3/2013C Richard StaffordDirectorSell15,000$14.06$210,900.00View SEC Filing  
9/3/2013John YetterCFOSell12,100$14.16$171,336.00View SEC Filing  
5/30/2013William C MartinMajor ShareholderSell95,568$13.68$1,307,370.24View SEC Filing  
4/29/2013Ra Capital Management, LlcMajor ShareholderBuy3,945$11.40$44,973.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Derma Sciences (NASDAQ:DSCI)
Latest Headlines for Derma Sciences (NASDAQ:DSCI)
Source:
DateHeadline
americanbankingnews.com logoDerma Sciences (DSCI) Receives News Sentiment Score of 0.06
www.americanbankingnews.com - April 27 at 10:06 PM
americanbankingnews.com logoDerma Sciences (DSCI) Getting Positive Press Coverage, Analysis Finds
www.americanbankingnews.com - April 21 at 2:37 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 8-K/A, Financial Statements and Exhibits
biz.yahoo.com - March 7 at 11:56 AM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or F
biz.yahoo.com - February 24 at 11:51 AM
streetinsider.com logoIntegra LifeSciences (IART) Says Tender Offer for Derma (DSCI) Expired; to Effect Merger Promptly - StreetInsider.com
www.streetinsider.com - February 23 at 9:48 PM
streetinsider.com logoIntegra LifeSciences (IART) Says Tender Offer for Derma (DSCI) Expired; to Effect Merger Promptly
www.streetinsider.com - February 23 at 4:48 PM
finance.yahoo.com logoIntegra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc.
finance.yahoo.com - February 23 at 4:48 PM
businesswire.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is ...
www.businesswire.com - January 27 at 6:27 PM
globenewswire.com logoIntegra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc. - GlobeNewswire (press release)
globenewswire.com - January 26 at 6:05 PM
finance.yahoo.com logoIntegra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc.
finance.yahoo.com - January 25 at 6:00 PM
finance.yahoo.com logoIntegra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc.
finance.yahoo.com - January 25 at 6:00 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - January 25 at 6:00 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - January 25 at 6:00 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Derma Sciences, Inc. - DSCI
finance.yahoo.com - January 20 at 11:04 PM
finance.yahoo.com logoDerma Sciences downgraded by ROTH Capital
finance.yahoo.com - January 18 at 5:10 PM
businesswire.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And ... - Business Wire (press release)
www.businesswire.com - January 17 at 10:41 PM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
finance.yahoo.com - January 17 at 10:41 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statemen
biz.yahoo.com - January 17 at 5:40 PM
finance.yahoo.com logoHarwood Feffer LLP Announces Investigation of Derma Sciences Inc.
finance.yahoo.com - January 17 at 5:40 PM
prnewswire.com logoDERMA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Derma Sciences, Inc. (DSCI ... - PR Newswire (press release)
www.prnewswire.com - January 15 at 4:40 PM
streetinsider.com logoIntegra LifeSciences (IART) to Acquire Derma Sciences (DSCI) for $7/Share, or 40% Premium
www.streetinsider.com - January 13 at 10:36 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Derma Sciences, Inc. -DSCI
finance.yahoo.com - January 13 at 10:35 PM
finance.yahoo.com logoDERMA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Derma Sciences, Inc. (DSCI) Over the Proposed Sale of the Company to Integra LifeSciences Holdings Corporation
finance.yahoo.com - January 13 at 5:34 PM
businesswire.com logoSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc ... - Business Wire (press release)
www.businesswire.com - January 12 at 10:35 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Investors To Contact The Firm For Additional Information
finance.yahoo.com - January 12 at 10:35 PM
investopedia.com logoIntegra Buys Derma Sciences for $204M (IART, DSCI)
www.investopedia.com - January 12 at 5:15 PM

Social

Chart

Derma Sciences (DSCI) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by MarketBeat.com Staff